- About
-
The Global ETD Search service is a free service for researchers
to find electronic theses and dissertations. This service is
provided by the
Networked Digital Library of Theses and Dissertations.
Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
Search results
Showing 11 to 20 of 20 (0.039 seconds)Spelling suggestions: "subject:"hbc"" "subject:"hbo""
| 11 |
Direct-To-Consumer Advertising of Genetic Tests Expands the Role of Obstetrician-GynecologistsGill, Carrie F. 07 October 2004 (has links)
No description available.
|
| 12 |
Motivations for Males Affected by HBOC to Disclose Genetic Health Information to Family Members and Health Care ProvidersSuttman, Alexandra Grace 29 August 2016 (has links)
No description available.
|
| 13 |
Expression, Purification, and Characterization of Mammalian and Earthworm HemoglobinsElmer, Jacob James 15 December 2011 (has links)
No description available.
|
| 14 |
Factors predicting <i>BRCA1</i> and <i>BRCA2</i> mutation carriers’ preference for communication of risk estimates.Crowdes, Sophie Rose 12 September 2016 (has links)
No description available.
|
| 15 |
Engineering Cellular Hemoglobin-Based Oxygen Carriers For Use In Transfusion MedicineRameez, Shahid 16 December 2011 (has links)
No description available.
|
| 16 |
Klinicko-genetické aspekty familiárního výskytu karcinomu prsuFrekvence rekurentních mutací v genech BRCA1 a BRCA2 v České republice / Clinical and genetic aspects of familial breast cancerFrequency of recurrent mutations in BRCA1 and BRCA2 genes in Czech republic and the role of NBN geneMatějů, Martin January 2014 (has links)
Summary: Background: An increased risk for development of hereditary breast cancer is associated with germline mutations in BRCA1/2 and the influence of NBN mutations is also supposed. The aim of this study is to specify the frequency of recurrent mutations in BRCA1/2 in unselected breast cancer patients and the frequency of most common pathogenic mutations in NBN in Czech republic, to assess current criteria for genetic testing and to consider the addition of NBN to the tested genes. Methods: Screening for recurrent mutations 5382insC and 300T>G in BRCA1 was performed by RFLP, screening for mutations in exon 11 of BRCA1 was performed by PTT, screening for mutations in a selected region of exon 11 of BRCA2 by DHPLC, and screening for mutations in exon 6 of NBN by HRMA. All the mutations were confirmed by direct sequencing. Results: In 679 unselected breast cancer patients 7 carriers of 5382insC, 3 of 300T>G, and 4 of other mutations in BRCA1 were identified. 2 locally prevalent mutations were found in BRCA2. In 730 controls only one 5382insC BRCA1 mutation was identified. Out of 5 NBN mutations found in 600 high-risk patients two were 657del5 and one R215W. A total of 8 NBN mutation carriers were identified among 703 breast cancer patients, 2 of them 657del5 carriers and three R215W carriers. In 915...
|
| 17 |
Klinicko-genetické aspekty familiárního výskytu karcinomu prsuFrekvence rekurentních mutací v genech BRCA1 a BRCA2 v České republice / Clinical and genetic aspects of familial breast cancerFrequency of recurrent mutations in BRCA1 and BRCA2 genes in Czech republic and the role of NBN geneMatějů, Martin January 2014 (has links)
Summary: Background: An increased risk for development of hereditary breast cancer is associated with germline mutations in BRCA1/2 and the influence of NBN mutations is also supposed. The aim of this study is to specify the frequency of recurrent mutations in BRCA1/2 in unselected breast cancer patients and the frequency of most common pathogenic mutations in NBN in Czech republic, to assess current criteria for genetic testing and to consider the addition of NBN to the tested genes. Methods: Screening for recurrent mutations 5382insC and 300T>G in BRCA1 was performed by RFLP, screening for mutations in exon 11 of BRCA1 was performed by PTT, screening for mutations in a selected region of exon 11 of BRCA2 by DHPLC, and screening for mutations in exon 6 of NBN by HRMA. All the mutations were confirmed by direct sequencing. Results: In 679 unselected breast cancer patients 7 carriers of 5382insC, 3 of 300T>G, and 4 of other mutations in BRCA1 were identified. 2 locally prevalent mutations were found in BRCA2. In 730 controls only one 5382insC BRCA1 mutation was identified. Out of 5 NBN mutations found in 600 high-risk patients two were 657del5 and one R215W. A total of 8 NBN mutation carriers were identified among 703 breast cancer patients, 2 of them 657del5 carriers and three R215W carriers. In 915...
|
| 18 |
When Bad Genes Ruin a Perfectly Good Outlook: Psychological Implications of Hereditary Breast and Ovarian Cancer via Narrative Inquiry MethodologyClark, Cammi 13 August 2019 (has links)
No description available.
|
| 19 |
Large Scale Synthesis of Polymerized Human Hemoglobin for Use as a Perfusate in <i>Ex Vivo</i> Normothermic Machine PerfusionCuddington, Clayton 09 September 2022 (has links)
No description available.
|
| 20 |
The Surgical and Management Decision-Making Process of <i>BRCA1</i> and <i>BRCA2</i> Mutation CarriersPuski, Athena Joy Bowen 12 September 2016 (has links)
No description available.
|
Page generated in 1.302 seconds